THE EFFECTS OF FATTY-ACIDS AND THEIR DERIVATIVES ON THE INTESTINAL-ABSORPTION OF INSULIN IN RAT

被引:25
作者
MURANUSHI, N [1 ]
MACK, E [1 ]
KIM, SW [1 ]
机构
[1] UNIV UTAH,DEPT PHARMACEUT,SALT LAKE CITY,UT 84108
关键词
D O I
10.3109/03639049309062992
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Insulin solution (25 U/ml/kg, pH 8.0) was administered with 50 mM of various C8-C18 fatty acid and derivative absorption enhancers to the duodenum, colon and rectum of fasted normal rats under sodium pentobarbital anesthesia. Solutions were administered directly into ligated or sealed intestinal segments. Blood was sampled periodically from the jugular vein and blood glucose levels determined. The maximum decrease inblood glucose level and area under the depression curve were used to estimate bioavailability. Enhancing effects rectally were further investigated in streptozotocin-induced diabetic rats in both the fasted and non-fasted states. Blood glucose levels and serum insulin concentrations were determined.
引用
收藏
页码:929 / 941
页数:13
相关论文
共 19 条
[1]  
BOHIDAR HB, 1984, BIOPOLYMERS, V23, P2407
[2]   RECTAL BIOAVAILABILITY OF LIDOCAINE IN RATS - ABSENCE OF SIGNIFICANT 1ST-PASS ELIMINATION [J].
DEBOER, AG ;
BREIMER, DD ;
PRONK, J ;
GUBBENSSTIBBE, JM .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1980, 69 (07) :804-807
[3]   EFFECT OF INFUSION OF INSULIN INTO PORTAL-VEIN ON HEPATIC EXTRACTION OF INSULIN IN ANESTHETIZED DOGS [J].
HARDING, PE ;
BLOOM, G ;
FIELD, JB .
AMERICAN JOURNAL OF PHYSIOLOGY, 1975, 228 (05) :1580-1588
[4]   NASAL ABSORPTION OF INSULIN IN DOGS [J].
HIRAI, S ;
IKENAGA, T ;
MATSUZAWA, T .
DIABETES, 1978, 27 (03) :296-299
[5]  
MATSUMOTO Y, 1989, CHEM PHARM BULL, V37, P2477
[6]  
MURAKAMI T, 1988, INT J PHARM, V46, P9
[7]  
MURANISHI S, 1979, INT J PHARM, V2, P101
[8]  
MURANUSHI N, 1980, INT J PHARM, V4, P271
[9]   ENHANCED BIOAVAILABILITY OF INSULIN AFTER RECTAL ADMINISTRATION WITH ENAMINE AS ADJUVANT IN DEPANCREATIZED DOGS [J].
NISHIHATA, T ;
OKAMURA, Y ;
KAMADA, A ;
HIGUCHI, T ;
YAGI, T ;
KAWAMORI, R ;
SHICHIRI, M .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1985, 37 (01) :22-26
[10]  
NISHIHATA T, 1983, J PHARM PHARM, V35